1[1]Yang CW,Li C,Jung JY,et al.Preeonditioning witherythropoietin protects against subsequent ischemiareperfusion injury in rat kidney[J].FASEB J,2003,17(12):1754.
2[2]Weishaupt JH,Rohde G,Polking E,et al.Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells[J].Invest Ophthalmol Vis Sci,2004,45 (5):1514.
3[3]Acs G,Chen M,Xu X,et al.Autqcrine erythropoietin signaling inhibits hypoxia-induced apoptosis in human breast carcinoma cells[J].Cancer Lett,2004,214 (2):243.
4[4]Gorio A,Gokmen N,Erbayraktar S,et al.Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma[J].Proc Natl Acad Sci USA,2002,99:9450-55.
5[5]Shurtz Swirski R,Kristal B,Shasha SM,et al.Interaction between erythropoietin and peripheral polymorphonuclear leukocytes in continuous ambulatory diaysis patients[J].Nephron.2002,91(4):759-761.
6[6]Villa P,Bigini P,Mennini T,et al.Erythropoietin selectively aRenuates cytokine production and inflammation in cerebral isehemia by targeting neuronal apoptos[J].Exp Ned,2003,198:971.
7[7]Patel NS,Sharpies EJ,Cuzzocrea S,et al.Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivo[J].Kidney Int,2004,66(3):983.
8[8]Sezpfin Y,Ersin A,CigdemT,et al.The protective effect of erythropoietin on ischaemia/reperfusion injury of liver[J].J Int Hepatol Pancreat Biliary Assoc,2004,6(3):169.
10[10]Noyan T,Onem O,Ramazan Sekeroglu M,et al.Effects of erythropoietin and pemoxifylline on the oxidant and antioxidant systems in the experimental short bowel syndrome[J].Cell Biochem Funct,2003,21 (1):49.
8[1]Azhar G, Liu L, Zhang X et al. Influence of age on hypoxia/reoxiygenation-induced DNA fragmentation and bcl-2, bcl-xl, bax and fas in the rat heart and brain[J]. Mech Aging Dev, 1999; 112(1): 5.
9[2]Agnello D, Bigini P, Villa P et al. Erythropoietin exerts an anti-inflammatory effect on the CNS in a model model of experimental autoimmune encephalitis[J]. Brain Res, 2002; 952(1): 128.
10[3]Wu H, Lee SH, Gao J et al. Inactivation of erythropietin leads to defects in cardiac morphogenesis[J]. Development, 1999; 126(16): 3597.
